Individual investors account for 50% of Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) ownership, while private equity firms account for 16%
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...
Macy’s Stock Falls Sharply on Slash to Guidance
Macy’s had postponed its third-quarter earnings report after finding an employee hid up to $150 million in expenses.